{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:50:15Z","timestamp":1765486215563},"publisher-location":"Singapore","reference-count":63,"publisher":"Springer Singapore","isbn-type":[{"type":"print","value":"9789811087264"},{"type":"electronic","value":"9789811087271"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-981-10-8727-1_5","type":"book-chapter","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T16:47:05Z","timestamp":1527612425000},"page":"63-76","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections"],"prefix":"10.1007","author":[{"given":"Emily N.","family":"Gallichotte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aravinda M.","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.virusres.2014.01.001","volume":"181","author":"JH Amorim","year":"2014","unstructured":"Amorim JH, Alves RP, Boscardin SB, Ferreira LC (2014) The dengue virus non-structural 1 protein: risks and benefits. Virus Res 181:53\u201360","journal-title":"Virus Res"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1086\/500949","volume":"193","author":"P Avirutnan","year":"2006","unstructured":"Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, Jairungsri A, Kanlaya R, Tangthawornchaikul N, Puttikhunt C, Pattanakitsakul SN, Yenchitsomanus PT, Mongkolsapaya J, Kasinrerk W, Sittisombut N, Husmann M, Blettner M, Vasanawathana S, Bhakdi S, Malasit P (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193:1078\u20131088","journal-title":"J Infect Dis"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"304ra141","DOI":"10.1126\/scitranslmed.aaa3787","volume":"7","author":"PR Beatty","year":"2015","unstructured":"Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E (2015) Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med 7:304ra141","journal-title":"Sci Transl Med"},{"key":"5_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nature12060","volume":"496","author":"S Bhatt","year":"2013","unstructured":"Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI (2013) The global distribution and burden of dengue. Nature 496:504\u2013507","journal-title":"Nature"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","volume":"23","author":"MH Collins","year":"2017","unstructured":"Collins MH, Mcgowan E, Jadi R, Young E, Lopez CA, Baric RS, Lazear HM, De Silva AM (2017) Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23:773\u2013781","journal-title":"Emerg Infect Dis"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ni.3081","volume":"16","author":"J Coloma","year":"2015","unstructured":"Coloma J, Harris E (2015) Broad and strong: the ultimate antibody to dengue virus. Nat Immunol 16:135\u2013137","journal-title":"Nat Immunol"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/infdis\/jiu481","volume":"211","author":"KS Corbett","year":"2015","unstructured":"Corbett KS, Katzelnick L, Tissera H, Amerasinghe A, De Silva AD, De Silva AM (2015) Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort. J Infect Dis 211:590\u2013599","journal-title":"J Infect Dis"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"e1188","DOI":"10.1371\/journal.pntd.0001188","volume":"5","author":"R Alwis De","year":"2011","unstructured":"De Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, De Silva AM (2011) In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Negl Trop Dis 5:e1188","journal-title":"PLoS Negl Trop Dis"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R De Alwis","year":"2012","unstructured":"De Alwis R, Smith SA, Olivarez NP, Messer WB, Huynh JP, Wahala WM, White LJ, Diamond MS, Baric RS, Crowe JE Jr, De Silva AM (2012) Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc Natl Acad Sci U S A 109:7439\u20137444","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jcv.2007.04.005","volume":"39","author":"VA Souza De","year":"2007","unstructured":"De Souza VA, Tateno AF, Oliveira RR, Domingues RB, Araujo ES, Kuster GW, Pannuti CS (2007) Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection. J Clin Virol 39:230\u2013233","journal-title":"J Clin Virol"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NT, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR (2015) A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol 16:170\u2013177","journal-title":"Nat Immunol"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"11726","DOI":"10.1128\/JVI.01140-14","volume":"88","author":"KA Dowd","year":"2014","unstructured":"Dowd KA, Mukherjee S, Kuhn RJ, Pierson TC (2014) Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition. J Virol 88:11726\u201311737","journal-title":"J Virol"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"e01559","DOI":"10.1128\/mBio.01559-15","volume":"6","author":"KA Dowd","year":"2015","unstructured":"Dowd KA, Demaso CR, Pierson TC (2015) Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing. MBio 6:e01559\u2013e01515","journal-title":"MBio"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/emmm.201303404","volume":"6","author":"G Fibriansah","year":"2014","unstructured":"Fibriansah G, Tan JL, Smith SA, De Alwis AR, Ng TS, Kostyuchenko VA, Ibarra KD, Wang JQ, Harris E, De Silva A, Crowe JE, Lok SM (2014) A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. Embo Molecular Medicine 6:358\u2013371","journal-title":"Embo Molecular Medicine"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","volume":"349","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, De Silva AM, Harris E, Crowe JE, Lok SM (2015a) DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349:88\u201391","journal-title":"Science"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/ncomms7341","volume":"6","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah G, Tan JL, Smith SA, De Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, De Silva AM, Crowe JE, Lok SM (2015b) A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat Commun 6:6341","journal-title":"Nat Commun"},{"key":"5_CR17","doi-asserted-by":"publisher","first-page":"e01461","DOI":"10.1128\/mBio.01461-15","volume":"6","author":"EN Gallichotte","year":"2015","unstructured":"Gallichotte EN, Widman DG, Yount BL, Wahala WM, Durbin A, Whitehead S, Sariol CA, Crowe JE, De Silva AM, Baric RS (2015) A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies. MBio 6:e01461\u2013e01415","journal-title":"MBio"},{"key":"5_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006178","volume":"13","author":"L Goo","year":"2017","unstructured":"Goo L, Vanblargan LA, Dowd KA, Diamond MS, Pierson TC (2017) A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis. PLoS Pathog 13:e1006178","journal-title":"PLoS Pathog"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.virol.2007.05.042","volume":"366","author":"GD Gromowski","year":"2007","unstructured":"Gromowski GD, Barrett AD (2007) Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366:349\u2013360","journal-title":"Virology"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","volume":"14","author":"B Guy","year":"2016","unstructured":"Guy B, Jackson N (2016) Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol 14:45\u201354","journal-title":"Nat Rev Microbiol"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","volume":"373","author":"SR Hadinegoro","year":"2015","unstructured":"Hadinegoro SR, Arredondo-Garcia JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortes M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M, CYD-TDV Dengue Vaccine Working Group (2015) Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 373:1195\u20131206","journal-title":"N Engl J Med"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.4049\/jimmunol.1500918","volume":"195","author":"A Hadjilaou","year":"2015","unstructured":"Hadjilaou A, Green AM, Coloma J, Harris E (2015) Single-cell analysis of B cell\/antibody cross-reactivity using a novel multicolor FluoroSpot assay. J Immunol 195:3490\u20133496","journal-title":"J Immunol"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","volume":"60","author":"SB Halstead","year":"2003","unstructured":"Halstead SB (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60:421\u2013467","journal-title":"Adv Virus Res"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"SB Halstead","year":"2007","unstructured":"Halstead SB (2007) Dengue. Lancet 370:1644\u20131652","journal-title":"Lancet"},{"key":"5_CR25","doi-asserted-by":"crossref","unstructured":"Halstead SB (2014) Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol Spectr 2","DOI":"10.1128\/microbiolspec.AID-0022-2014"},{"key":"5_CR26","doi-asserted-by":"crossref","unstructured":"Halstead SB (2015) Pathogenesis of dengue: Dawn of a new era. F1000Res 4","DOI":"10.12688\/f1000research.7024.1"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4269\/ajtmh.1983.32.154","volume":"32","author":"SB Halstead","year":"1983","unstructured":"Halstead SB, Rojanasuphot S, Sangkawibha N (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32:154\u2013156","journal-title":"Am J Trop Med Hyg"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"14722","DOI":"10.1038\/ncomms14722","volume":"8","author":"SS Hasan","year":"2017","unstructured":"Hasan SS, Miller A, Sapparapu G, Fernandez E, Klose T, Long F, Fokine A, Porta JC, Jiang W, Diamond MS, Crowe JE Jr, Kuhn RJ, Rossmann MG (2017) A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat Commun 8:14722","journal-title":"Nat Commun"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/jmv.1890450417","volume":"45","author":"RT He","year":"1995","unstructured":"He RT, Innis BL, Nisalak A, Usawattanakul W, Wang S, Kalayanarooj S, Anderson R (1995) Antibodies that block virus attachment to Vero cells are a major component of the human neutralizing antibody response against dengue virus type 2. J Med Virol 45:451\u2013461","journal-title":"J Med Virol"},{"key":"5_CR30","first-page":"351","volume":"215","author":"S Henein","year":"2017","unstructured":"Henein S, Swanstrom J, Byers AM, Moser JM, Shaik SF, Bonaparte M, Jackson N, Guy B, Baric R, De Silva AM (2017) Dissecting antibodies induced by a chimeric yellow fever-dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and dengue-exposed individuals. J Infect Dis 215:351\u2013358","journal-title":"J Infect Dis"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"18950","DOI":"10.1073\/pnas.1011036107","volume":"107","author":"B Kaufmann","year":"2010","unstructured":"Kaufmann B, Vogt MR, Goudsmit J, Holdaway HA, Aksyuk AA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG (2010) Neutralization of West Nile virus by cross-linking of its surface proteins with fab fragments of the human monoclonal antibody CR4354. Proc Natl Acad Sci U S A 107:18950\u201318955","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.virol.2015.03.025","volume":"479\u2013480","author":"RJ Kuhn","year":"2015","unstructured":"Kuhn RJ, Dowd KA, Beth Post C, Pierson TC (2015) Shake, rattle, and roll: impact of the dynamics of flavivirus particles on their interactions with the host. Virology 479\u2013480:508\u2013517","journal-title":"Virology"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri3802","volume":"15","author":"T Kurosaki","year":"2015","unstructured":"Kurosaki T, Kometani K, Ise W (2015) Memory B cells. Nat Rev Immunol 15:149\u2013159","journal-title":"Nat Rev Immunol"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nm.2071","volume":"16","author":"MJ Kwakkenbos","year":"2010","unstructured":"Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, Van Geelen CM, Lukens MV, Van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA, Spits H, Beaumont T (2010) Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming. Nat Med 16:123\u2013128","journal-title":"Nat Med"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1086\/343813","volume":"186","author":"DH Libraty","year":"2002","unstructured":"Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, Vaughn DW, Nisalak A, Ennis FA, Rothman AL (2002) High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 186:1165\u20131168","journal-title":"J Infect Dis"},{"key":"5_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2016.74","volume":"5","author":"Y Liu","year":"2016","unstructured":"Liu Y, Liu J, Cheng G (2016) Vaccines and immunization strategies for dengue prevention. Emerg Microbes Infect 5:e77","journal-title":"Emerg Microbes Infect"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1128\/JCM.43.6.2793-2797.2005","volume":"43","author":"S Matheus","year":"2005","unstructured":"Matheus S, Deparis X, Labeau B, Lelarge J, Morvan J, Dussart P (2005) Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. J Clin Microbiol 43:2793\u20132797","journal-title":"J Clin Microbiol"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1128\/JVI.00155-16","volume":"90","author":"WB Messer","year":"2016","unstructured":"Messer WB, Yount BL, Royal SR, De Alwis R, Widman DG, Smith SA, Crowe JE Jr, Pfaff JM, Kahle KM, Doranz BJ, Ibarra KD, Harris E, De Silva AM, Baric RS (2016) Functional transplant of a dengue virus serotype 3 (DENV3)-specific human monoclonal antibody epitope into DENV1. J Virol 90:5090\u20135097","journal-title":"J Virol"},{"key":"5_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2016.06.022","volume":"497","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Sirohi D, Dowd KA, Chen Z, Diamond MS, Kuhn RJ, Pierson TC (2016) Enhancing dengue virus maturation using a stable furin over-expressing cell line. Virology 497:33\u201340","journal-title":"Virology"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.antiviral.2013.03.008","volume":"98","author":"DA Muller","year":"2013","unstructured":"Muller DA, Young PR (2013) The flavivirus NS1 protein: molecular and structural biology, immunology, role in pathogenesis and application as a diagnostic biomarker. Antivir Res 98:192\u2013208","journal-title":"Antivir Res"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"e02041","DOI":"10.1128\/JVI.02041-16","volume":"91","author":"UK Nivarthi","year":"2017","unstructured":"Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JEJ, De Silva AM (2017) Mapping the human memory B cell and serum neutralizing antibody responses to dengue virus serotype 4 infection and vaccination. J Virol 91:e02041\u2013e02016","journal-title":"J Virol"},{"key":"5_CR42","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski S, Forshey BM, Morrison AC, Rocha C, Vilcarromero S, Halsey ES, Kochel TJ, Scott TW, Stoddard ST (2013) Reduced risk of disease during postsecondary dengue virus infections. J Infect Dis 208:1026\u20131033","journal-title":"J Infect Dis"},{"key":"5_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005554","volume":"11","author":"B Patel","year":"2017","unstructured":"Patel B, Longo P, Miley MJ, Montoya M, Harris E, De Silva AM (2017) Dissecting the human serum antibody response to secondary dengue virus infections. PLoS Negl Trop Dis 11:e0005554","journal-title":"PLoS Negl Trop Dis"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/nrrheum.2014.220","volume":"11","author":"WH Robinson","year":"2015","unstructured":"Robinson WH (2015) Sequencing the functional antibody repertoire\u2014diagnostic and therapeutic discovery. Nat Rev Rheumatol 11:171\u2013182","journal-title":"Nat Rev Rheumatol"},{"key":"5_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","volume":"59","author":"JT Roehrig","year":"2003","unstructured":"Roehrig JT (2003) Antigenic structure of flavivirus proteins. Adv Virus Res 59:141\u2013175","journal-title":"Adv Virus Res"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","volume":"11","author":"AL Rothman","year":"2011","unstructured":"Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol 11:532\u2013543","journal-title":"Nat Rev Immunol"},{"key":"5_CR47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Despres P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA (2015) Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520:109\u2013113","journal-title":"Nature"},{"key":"5_CR48","doi-asserted-by":"crossref","unstructured":"Smith SA, Crowe JE Jr (2015) Use of human Hybridoma technology to isolate human monoclonal antibodies. Microbiol Spectr 3, AID-0027-2014","DOI":"10.1128\/microbiolspec.AID-0027-2014"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nprot.2009.3","volume":"4","author":"K Smith","year":"2009","unstructured":"Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, Wilson PC (2009) Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 4:372\u2013384","journal-title":"Nat Protoc"},{"key":"5_CR50","first-page":"e00873","volume":"4","author":"SA Smith","year":"2013","unstructured":"Smith SA, De Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, De Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE Jr (2013) The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio 4:e00873\u2013e00813","journal-title":"MBio"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1128\/JVI.01805-15","volume":"90","author":"SA Smith","year":"2015","unstructured":"Smith SA, Nivarthi UK, De Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, De Silva AM, Crowe JE Jr (2015) Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single Immunodominant antigenic site. J Virol 90:780\u2013789","journal-title":"J Virol"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, Foglierini M, Pedotti M, Simonelli L, Dowall S, Atkinson B, Percivalle E, Simmons CP, Varani L, Blum J, Baldanti F, Cameroni E, Hewson R, Harris E, Lanzavecchia A, Sallusto F, Corti D (2016) Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353:823\u2013826","journal-title":"Science"},{"key":"5_CR53","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1128\/JVI.00432-07","volume":"81","author":"S Sukupolvi-Petty","year":"2007","unstructured":"Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS (2007) Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol 81:12816\u201312826","journal-title":"J Virol"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"139ra83","DOI":"10.1126\/scitranslmed.3003888","volume":"4","author":"EP Teoh","year":"2012","unstructured":"Teoh EP, Kukkaro P, Teo EW, Lim AP, Tan TT, Yip A, Schul W, Aung M, Kostyuchenko VA, Leo YS, Chan SH, Smith KG, Chan AH, Zou G, Ooi EE, Kemeny DM, Tan GK, Ng JK, Ng ML, Alonso S, Fisher D, Shi PY, Hanson BJ, Lok SM, Macary PA (2012) The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci Transl Med 4:139ra83","journal-title":"Sci Transl Med"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1128\/JVI.00871-13","volume":"87","author":"WY Tsai","year":"2013","unstructured":"Tsai WY, Lai CY, Wu YC, Lin HE, Edwards C, Jumnainsong A, Kliks S, Halstead S, Mongkolsapaya J, Screaton GR, Wang WK (2013) High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J Virol 87:12562\u201312575","journal-title":"J Virol"},{"key":"5_CR56","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1128\/JVI.00273-15","volume":"89","author":"WY Tsai","year":"2015","unstructured":"Tsai WY, Durbin A, Tsai JJ, Hsieh SC, Whitehead S, Wang WK (2015) Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol 89:7348\u20137362","journal-title":"J Virol"},{"key":"5_CR57","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.virol.2009.06.037","volume":"392","author":"WM Wahala","year":"2009","unstructured":"Wahala WM, Kraus AA, Haymore LB, Accavitti-Loper MA, De Silva AM (2009) Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody. Virology 392:103\u2013113","journal-title":"Virology"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"369ra179","DOI":"10.1126\/scitranslmed.aai8336","volume":"8","author":"Q Wang","year":"2016","unstructured":"Wang Q, Yang H, Liu X, Dai L, Ma T, Qi J, Wong G, Peng R, Liu S, Li J, Li S, Song J, Liu J, He J, Yuan H, Xiong Y, Liao Y, Li J, Yang J, Tong Z, Griffin BD, Bi Y, Liang M, Xu X, Qin C, Cheng G, Zhang X, Wang P, Qiu X, Kobinger G, Shi Y, Yan J, Gao GF (2016) Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci Transl Med 8:369ra179","journal-title":"Sci Transl Med"},{"key":"5_CR59","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1126\/science.1153264","volume":"319","author":"IM Yu","year":"2008","unstructured":"Yu IM, Zhang W, Holdaway HA, Li L, Kostyuchenko VA, Chipman PR, Kuhn RJ, Rossmann MG, Chen J (2008) Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319:1834\u20131837","journal-title":"Science"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"12101","DOI":"10.1128\/JVI.01637-09","volume":"83","author":"IM Yu","year":"2009","unstructured":"Yu IM, Holdaway HA, Chipman PR, Kuhn RJ, Rossmann MG, Chen J (2009) Association of the pr peptides with dengue virus at acidic pH blocks membrane fusion. J Virol 83:12101\u201312107","journal-title":"J Virol"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"8761","DOI":"10.1073\/pnas.1306333110","volume":"110","author":"S Zompi","year":"2013","unstructured":"Zompi S, Harris E (2013) Original antigenic sin in dengue revisited. Proc Natl Acad Sci U S A 110:8761\u20138762","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001568","volume":"6","author":"S Zompi","year":"2012","unstructured":"Zompi S, Montoya M, Pohl MO, Balmaseda A, Harris E (2012) Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans. PLoS Negl Trop Dis 6:e1568","journal-title":"PLoS Negl Trop Dis"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1099\/vir.0.2008\/002535-0","volume":"89","author":"IA Zybert","year":"2008","unstructured":"Zybert IA, Van Der Ende-Metselaar H, Wilschut J, Smit JM (2008) Functional importance of dengue virus maturation: infectious properties of immature virions. J Gen Virol 89:3047\u20133051","journal-title":"J Gen Virol"}],"container-title":["Advances in Experimental Medicine and Biology","Dengue and Zika: Control and Antiviral Treatment Strategies"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-10-8727-1_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T19:45:34Z","timestamp":1571427934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-10-8727-1_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9789811087264","9789811087271"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-981-10-8727-1_5","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[2018]]}}}